Evidence Based Evaluation of Traditional Chinese Medicine Prevention and Treatment Program for Children with Influenza

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients diagnosed with influenza A (H1N1, H3N2) or influenza B virus according to real-time polymerase chain reaction (PCR) or virus culture;
•2. Patients aged 5 to 14 years old;
•3. Patients with axillary temperature = 38 ?;
•4. Patients with at least two general symptoms (headache, chills, myalgia or fatigue) and one respiratory symptom (cough, sore throat or rhinitis);
•5. Patients who meet the diagnostic criteria of TCM syndromes;
•6. Patients with a course of disease within 72 hours;
•7. Patients with written informed consent.

•1. Patients with bronchitis, pneumonia, pleural effusion and interstitial lung disease on chest X-ray;
•2. Patients with bacterial infection indicated by blood routine examination;
•3. Patients with suppurative tonsillitis or purulent sputum;
•4. Patients with primary diseases, such as blood diseases, bronchial asthma, liver diseases, kidney diseases, chronic congestive heart failure and nervous system diseases;
•5. Patients who had taken antiviral drugs (amantadine, rimantadine, zanamivir or oseltamivir phosphate) before the onset and enrollment of the study, or took Chinese herbal medicine or proprietary Chinese medicine.
•6. Patients allergic to the study drug;
•7. Patients who have taken immunosuppressants in the last 3 months;
•8. Patients who participated in another clinical trial within 3 months before participating in this trial;
•9. Patients with acute respiratory tract infection, otitis or sinusitis 2 weeks before enrollment;
•10. Patients who have been vaccinated with influenza vaccine within 6 months;
•11. Other reasons considered by the researchers.

发起方

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine